26.1 C
Vientiane
Saturday, September 6, 2025
spot_img
Home Blog Page 1455

Stroke Detection Innovator Wellumio Enrolls First Patient in Australian Clinical Trial for ‘Axana’ 0.1T portable magnetic resonance imaging device (Portable MRI study)

“Revolutionary portable device leverages advanced magnetic resonance technology to rapidly detect acute stroke biomarkers, enabling frontline care teams to make faster, life-saving decisions within the critical ‘golden hour.”

A Melbourne hospital images the first patient in Australia using the Wellumio Axana device, marking a milestone in advancing rapid acute stroke detection in the Emergency Room.

With a unique ability to perform rapid MRI-based stroke imaging at the patient’s bedside, Wellumio takes a major step toward generating the clinical evidence required for adoption of the Axana device.

MELBOURNE, Australia, Feb. 7, 2025 /PRNewswire/ — Wellumio, a New Zealand-based medical device company pioneering advancements in stroke detection, today announced enrollment of the first patient in the Feasibility, safety, and usability assessment of the Wellumio ‘Axana’ 0.1T portable magnetic resonance imaging device (Portable MRI study) which will study the ability of the Axana device to detect acute stroke in ED patients. The Axana device, through its compact, portable design, enables the user to rapidly track the magnetic resonance properties of brain tissue and identify clinically proven stroke biomarkers, such as molecular diffusion identified by Diffusion Weighted Imaging (DWI) at the patient’s bedside. 

The Melbourne hospital recently assessed the first case using the Wellumio Axana device. The care team there performed the scan on a 77-year-old female suspected of acute stroke with the Wellumio Axana device.

The Portable MRI study is a two-part, dual-center, feasibility/ observational study of the Wellumio ‘Axana’ 0.1T brain scanning device in subacute stroke patients. The primary objective of this first clinical study is to assess the safety (adverse events) and feasibility (ability to acquire a scan in a timely manner without technical fault) of the Wellumio ‘Axana’ device in the hospital setting with healthy controls and stroke patients. Secondary objectives include 1) assessing usability of the Axana device, 2) acquiring physiological data from healthy controls and hospital patients with the Axana device to investigate the agreement with hospital MRI, and 3) investigating the repeatedly and reproducibility of scans acquired with the Axana device within and between participants.

The clinical study is supported by the Australian Stroke Alliance, principal study partner, and managed by Titan Prehospital Innovation, a Clinical Research Organisation in partnership with the Australian Stroke Alliance.

“This innovative imaging approach to stroke detection has the potential to accelerate treatment and improve patient outcomes. MRI techniques have the potential to sensitively diagnose stroke,” said Professor Stephen Davis, co-principal investigator.

“Integrating this type of technology in the pre-existing workflow by bringing MRI imaging to the patient has the potential, if successful, to improve acute stroke assessment and treatment. That makes this an exciting innovation milestone as we enroll the first patient in this important first clinical trial,” added Professor Geoffrey Donnan, co-principal investigator.

“We’ve designed a novel device that is highly portable and significantly faster than traditional MRIs, making it ideal for quick assessments in emergency situations,” said Dr. Shieak Tzeng, CEO of Wellumio. “By delivering radial maps of the brain, Axana will potentially empower emergency physicians, neurologists, radiologists, and stroke care team members to rapidly detect strokes and guide critical treatment decisions during the crucial golden hour of care.”

Unlike conventional MRIs, which rely on superconducting magnets and large coils to generate magnetic gradients for imaging, Axana’s innovative technology is powered by Pulsed Gradient Free Mapping (PGFM). This groundbreaking approach eliminates the need for bulky components, enabling the device to track the magnetic resonance properties of brain tissue and identify clinically proven stroke biomarkers, such as molecular diffusion, in a compact, portable design.

Axana’s portability and simplicity make it ideal for bedside use, where it enables fast detection of stroke-related damage and provides critical insights into its severity and extent. By delivering this information quickly, Axana supports the prioritization of advanced imaging and guides urgent treatment decisions.

About Wellumio
Wellumio is a New Zealand-based medical device company transforming acute stroke care with its innovative Axana® device. The portable, lightweight technology utilizes a groundbreaking Pulsed Gradient Free Mapping (PGFM) method to rapidly identify areas of brain tissue affected by stroke. Designed to address the limitations of traditional MRI systems, Axana enables frontline healthcare workers in diverse settings, including emergency departments and ICUs, to make timely, life-saving interventions within the critical golden hour, leading to better patient outcomes. To learn more, visit www.wellumio.com

Logo – https://laotiantimes.com/wp-content/uploads/2025/02/copy_of_99d_wellumio_logo_rgb_wellumio_main_logo.jpg

PT Lippo General Insurance Tbk (LGI) Unveils MyGo+: A Telematics-Based App for Safer Driving

JAKARTA, Indonesia, Feb. 6, 2025 /PRNewswire/ — PT Lippo General Insurance Tbk (LGI), a leading general insurance company in Indonesia, has announced the launch of MyGo+, a telematics-based app designed to encourage safer driving habits. The app analyzes real-time driving data to inform driving behavior and provides a reward system to motivate responsible driving, supporting Indonesia’s efforts to improve road safety and reduce traffic accident rates.

‘MyGo+’ app interface – Empowering safer driving with AI-powered insights, real-time rewards, and driving challenges, marking a milestone in PT Lippo General Insurance Tbk's digital innovation journey under Hanwha Life Insurance.
‘MyGo+’ app interface – Empowering safer driving with AI-powered insights, real-time rewards, and driving challenges, marking a milestone in PT Lippo General Insurance Tbk’s digital innovation journey under Hanwha Life Insurance.

‘MyGo+’ app interface – Empowering safer driving with AI-powered insights, real-time rewards, and driving challenges, marking a milestone in PT Lippo General Insurance Tbk’s digital innovation journey under Hanwha Life Insurance.

MyGo+ offers a range of features to help drivers develop safer habits. By analyzing data such as distance traveled and acceleration patterns, the app generates driving scores that are converted into reward points in real time. These points can be redeemed for vouchers, and users can participate in monthly driving challenges to earn additional benefits.

Key Features of MyGo+:

  • Driving Behavior Analysis: Data insights to encourage responsible driving
  • Monthly Driving Challenges: Gamified challenges with additional benefits
  • Reward Points: Real-time points awarded for safe driving
  • Voucher Redemption: Reward points redeemed for attractive vouchers  

MyGo+ represents the first digital innovation introduced since the LGI became part of Hanwha Life Insurance following its acquisition in March 2023. In line with Hanwha Life Insurance’s vision to become a comprehensive digital-based financial services provider, MyGo+ leverages advanced technologies, including AI and machine learning. These capabilities ensure accurate driving data collection by mitigating potential errors caused by external factors such as road conditions or network environments.

Developed for public benefit, the app is accessible to all drivers, not just LGI insurance policyholders. Additionally, users can enjoy discounts and other benefits when purchasing LGI insurance products.

Ricky Choi, Vice President Director of PT Lippo General Insurance Tbk, remarked: “MyGo+ is a transformative step in blending technology with customer engagement. It promotes safer driving and offers meaningful rewards, benefiting both users and our continuous innovation efforts. This app marks a major milestone in our journey to become a digital leader in the insurance industry, and we look forward to introducing even more innovations in the future.”

MyGo+ is now available for free download on both iOS and Android. Download MyGo+ today to start earning rewards for safer driving while contributing to Indonesia’s road safety efforts. For more information, visit the LGI website.

About PT Lippo General Insurance Tbk (LGI)

LGI is one of the leading general insurance companies that has been operating for more than 40 years, serving individual and corporate clients with various innovative insurance solutions, including health, property, motor vehicle, transportation, engineering, liability, and personal accident insurance.

LGI supports financial digitalization through its eBenefit Health, eBenefit General, Myprotection.id, and MyGo+ applications and has met the quality standards of ISO 9001:2015 for Health Services Operation,  ISO 9001:2015 for Non-Health Services Operation and ISO 27001:2013 for Information Security Management System of Internal Data Center Infrastructure Operations.

Recognized as a trusted insurance company, LGI has achieved asset growth exceeding IDR 2.7+ trillion and a Risk-Based Capital (RBC) ratio of over 330% by the end of 2023, surpassing the government requirement of at least 120%. Additionally, LGI has received numerous awards from Media Asuransi, SWA, and Business Digest, among others. LGI is also a company of Hanwha, a global South Korean conglomerate.

*PT Lippo General Insurance Tbk is licensed and supervised by Financial Services Authority (OJK) 

MicroCloud Hologram Inc. Announces the Integration of DeepSeek R1 Model’s Semantic Understanding Technology into Holographic Digital Humans

SHENZHEN, China, Feb. 6, 2025 /PRNewswire/ — MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, they have announced a significant technological breakthrough—the integration of the DeepSeek large model API application. This initiative aims to provide users with a more natural and seamless interaction experience, as well as more proactive services. This move marks a solid step forward for MicroCloud Hologram in the field of holographic digital human technology and further accelerates the humanization of AI-driven conversational systems.

DeepSeek’s large model API is based on the Transformer architecture. Through pre-training on massive amounts of corpus data and fine-tuning, it possesses powerful language understanding and generation capabilities. The DeepSeek API not only supports dialogue generation and completion, but is also widely used in various fields such as text generation, question-answering systems, and text summarization, demonstrating excellent performance and broad application prospects.

HOLO’s integration of the DeepSeek large model API aims to enhance the intelligent interaction capabilities of its Holographic Digital Human GPT. The Holographic Digital Human GPT, developed by HOLO, is an AI-driven holographic digital human that can be displayed using holographic projection technology. It combines advanced technologies such as computer graphics, graphical rendering, motion capture, deep learning, and speech synthesis, offering high levels of visual realism, natural interaction, and performance abilities. By integrating the DeepSeek large model API, the language understanding and generation capabilities of the Holographic Digital Human GPT have been significantly improved, allowing it to more accurately understand user intent and provide more precise and valuable information.

On the technical implementation side, HOLO has employed several innovative techniques to ensure the effective integration of the DeepSeek large model API. First, HOLO has deeply customized and optimized the DeepSeek API to meet the specific needs of the Holographic Digital Human GPT. By adjusting API interface parameters and configurations, HOLO has achieved seamless integration with the DeepSeek large model, ensuring accurate information transmission and efficient processing.

Furthermore, HOLO has introduced advanced semantic understanding technologies into the Holographic Digital Human GPT. By combining the semantic analysis capabilities of the DeepSeek large model, the Holographic Digital Human GPT is able to gain a deeper understanding of the text input by users, identify key information and intent, and provide more accurate responses and thoughtful services. For example, in a chat scenario, the Holographic Digital Human GPT can accurately detect the user’s emotional tendencies and topics of interest, actively guiding the conversation and creating a more natural and harmonious chatting atmosphere.

In addition, HOLO has fully leveraged the powerful generation capabilities of the DeepSeek large model to give the Holographic Digital Human GPT a richer expressive ability. Whether it’s writing articles, creating poetry, or engaging in professional Q&A, the Holographic Digital Human GPT can generate high-quality text content according to user needs. The generated text is natural, fluent, and logically coherent, effectively meeting the diverse needs of users.

It is worth mentioning that during the integration of the DeepSeek large model API, HOLO has also taken comprehensive measures to address security and privacy protection. By employing advanced encryption technologies and stringent data access control mechanisms, HOLO ensures the safety and confidentiality of user data. Additionally, HOLO has established a thorough error-handling and logging system to quickly pinpoint and resolve any issues that may arise.

With the successful integration of the DeepSeek large model API, HOLO’s Holographic Digital Human GPT has achieved significant improvements in both interaction experience and service quality. Users can now enjoy a more natural and seamless conversational experience through the Holographic Digital Human GPT, whether they are asking questions, obtaining information, or engaging in entertainment interactions, all while receiving timely and accurate responses and thoughtful services. Additionally, HOLO plans to apply Holographic Digital Human GPT technology to more fields and industries, such as aerospace, automotive manufacturing, machinery manufacturing, furniture design, fashion, telecommunications, and healthcare, to provide more users with smarter and more convenient services.

Looking ahead, HOLO will continue to focus on the research and development of holographic technologies, consistently advancing the humanization process of AI-driven conversational systems. Through ongoing technological innovation and optimization, HOLO aims to deliver an even higher-quality Holographic Digital Human GPT experience for users and promote the widespread adoption and development of artificial intelligence technology.

About MicroCloud Hologram Inc.

MicroCloud is committed to providing leading holographic technology services to its customers worldwide. MicroCloud’s holographic technology services include high-precision holographic light detection and ranging (“LiDAR”) solutions, based on holographic technology, exclusive holographic LiDAR point cloud algorithms architecture design, breakthrough technical holographic imaging solutions, holographic LiDAR sensor chip design and holographic vehicle intelligent vision technology to service customers that provide reliable holographic advanced driver assistance systems (“ADAS”). MicroCloud also provides holographic digital twin technology services for customers and has built a proprietary holographic digital twin technology resource library. MicroCloud’s holographic digital twin technology resource library captures shapes and objects in 3D holographic form by utilizing a combination of MicroCloud’s holographic digital twin software, digital content, spatial data-driven data science, holographic digital cloud algorithm, and holographic 3D capture technology. For more information, please visit http://ir.mcholo.com/

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate,” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company’s goals and strategies; the Company’s future business development; product and service demand and acceptance; changes in technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic; financial condition and results of operations; the expected growth of the holographic industry and business conditions in China and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the Securities and Exchange Commission (“SEC”), including the Company’s most recently filed Annual Report on Form 10-K and current report on Form 6-K and its subsequent filings. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

Guangdong Accelerates Construction of a Modern Industrial System with Greater International Competitiveness

GUANGZHOU, China, Feb. 6, 2025 /PRNewswire/ — On February 5, 2025, the first working day of the Year of the Snake, Guangdong held a provincial high-quality development conference in Guangzhou to conduct in-depth exchanges and discussions on accelerating the construction of a modern industrial system. For three consecutive years, Guangdong’s “first meeting after the Spring Festival” has focused on high-quality development, demonstrating not only the importance of high-quality development to the province’s modernization but also the province’s strategic determination to advance high-quality development in a down-to-earth manner.

CPC Guangdong Committee’s Secretary Huang Kunming delivers a speech at the provincial high-quality development conference.
CPC Guangdong Committee’s Secretary Huang Kunming delivers a speech at the provincial high-quality development conference.

Huang Kunming, Secretary of CPC Guangdong Committee, delivered a speech at the conference. Guangdong Governor Wang Weizhong presided over the conference. Huang Chuping, Director of the Standing Committee of the Provincial People’s Congress; Lin Keqing, Chairman of the Provincial Committee of the CPPCC; Yang Yinkai, Deputy Director of the Central Finance Office; and Meng Fanli, Deputy Secretary of the CPC Guangdong Committee and Secretary of the CPC Shenzhen Committee, attended the conference.

According to Huang Kunming, to advance the Chinese-style modernization, building a modern industrial system is an essential and strong support. Shouldering the mission of pioneering in the journey, Guangdong should play an exemplary role in driving the modernization of the industrial system, and establish a powerful new image based on a modern industrial system with greater international competitiveness. Guangdong’s industrial system has grown up through open cooperation, and continuously improved through transformation and upgrading.

So, in the new round of sci-tech revolution and industrial transformation, Guangdong should strive to take the lead to comprehensively optimize and upgrade its industrial system. Then, the province will shake off the low-end industrial sectors, seize the commanding heights, and present a rising and booming new image of Guangdong based on a modern industrial system with greater international competitiveness.

Guangdong boasts a complete industrial system, a strong industrial supporting system and a sufficient industrial development space. The province has also built its solid industrial foundation and unique industrial competitiveness during its long-term development. We should turn its positive factors into development achievements, and use its modern industrial system with greater international competitiveness to boost a new Guangdong featuring prosperous economy and society and robust vitality.

Huang also emphasized that we should consolidate and optimize traditional and competitive industries with one hand, and cultivate and nurture emerging and future industries with the other, focusing on the two major sectors of AI and robotics and striving to build new industrial pillars featuring high-tech, high-growth and large scale. We should fully activate the policy effect, continue to optimize the business environment, and team up with Hong Kong and Macao to accelerate the construction of a high-level talent highland, implement the “Action Plan for Attracting A Million Talents to South Guangdong” and comprehensively consolidate the talent base for the modern industrial system.

Wang Weizhong pointed out that we should vigorously drive the upgrading of the industrial base and the modernization of the industrial chain, and accelerate the construction of a modern industrial system with greater international competitiveness. We should adhere to the real economy-oriented and manufacturing-dominated development concept, consolidate and upgrade 20 strategic industrial clusters, develop and expand emerging and future industries like AI and robotics, and forge and nurture new quality productive forces. We should boost the mutual promotion and development of industries and sci-tech, accelerate the construction of the whole process innovation chain, strengthen the research on key core technologies, improve the platform systems for concept and pilot tests, and build industrial sci-tech innovation centers with global influence.

WeRide Launches Robovan W5, Pioneering New Class of Autonomous Delivery Vehicle

GUANGZHOU, China, Feb. 6, 2025 /PRNewswire/ — WeRide Inc. (NASDAQ: WRD), a global leader in autonomous driving technology, today launched the Robovan W5, featuring self-developed Level 4 autonomous technology that operates 24/7 in all weather conditions. It offers long-distance and bulk delivery capabilities integrating vehicle, cloud, and operations to address key challenges in the logistics industry, particularly in express delivery, urban distribution and various point-to-point logistics, with a cost-effective unmanned delivery solution.

WeRide (NASDAQ: WRD) launches the Robovan W5, featuring self-developed Level 4 autonomous technology that operates 24/7 in all weather conditions.
WeRide (NASDAQ: WRD) launches the Robovan W5, featuring self-developed Level 4 autonomous technology that operates 24/7 in all weather conditions.

As a Level 4 autonomous logistics vehicle designed for urban open roads, Robovan W5 is built on WeRide’s almost 1,900 days of autonomous operations, and nearly 40 million kilometers of autonomous driving mileage on public roads. It features WeRide’s self-designed redundant sensor kit, which detects vehicles, traffic lights, pedestrians, and other road users, while providing 360-degree blind-spot-free perception to operate 24/7 in various traffic conditions. 

The WeRide Robovan W5 is tailored for high-frequency urban logistics. Features include the largest cargo capacity in its class at 5.5 cubic meters with 1,000 kg maximum payload, and operating range of up to 220 kilometers. The Robovan W5 navigates complex urban traffic environments with an intelligent path optimization system that analyzes traffic conditions in real-time, dynamically adjusting routes to avoid congestion. It allows modular cargo box stacking for different scenarios.

The Robovan W5 supports multi-vehicle platooning, allowing single-operator management of multiple vehicles for standardized, scalable delivery. Its electric drive and 24/7 operations further reduce operation costs. 

Safety features include redundant drive-by-wire chassis, redundant perception, emergency braking, collision warning, driving status monitoring and intelligent Cloud Control Platform.  

Service features include cloud-based intelligent scheduling, real-time monitoring, task optimization, and data analytics, rapid deployment, and remote OTA upgrades. WeRide also provides 24/7 customer support, on-site training, customized solutions, comprehensive warranty, complimentary maintenance, vehicle replacement for quality issues, and IoT.

“The Robovan W5 demonstrates WeRide’s latest breakthrough in autonomous delivery and ability to adapt WeRide’s proven autonomous driving technology across different urban scenarios with our self-developed universal autonomous driving technology platform WeRide One,” said Dr. Tony Han, Founder and CEO of WeRide. “From our GXR Robotaxi serving passengers and Robosweeper cleaning the urban environment to the Robovan W5 handling urban logistics, we’re creating a comprehensive ecosystem of autonomous driving solutions to cover diverse urban transportation needs.”

ST Engineering iDirect Demonstrates Public Safety Connectivity with Verizon Frontline at Super Bowl LIX

Revolutionizing emergency response through cutting-edge satellite technology

HERNDON, Va., Feb. 6, 2025 /PRNewswire/ — ST Engineering iDirect, a global leader in satellite communications, will be showcasing its pivotal role in advancing public safety solutions through its partnership with Verizon Frontline, an advanced network and technology built for first responders, at an exclusive event for public safety officials to be held ahead of the Super Bowl in New Orleans.

Hosted by Verizon Frontline, the event will highlight its range of innovative solutions designed to deliver vital connectivity in emergency scenarios. Powered in part by ST Engineering iDirect’s state-of-the-art satellite communication technology, Verizon Frontline’s advanced tactical assets on display include:

  • Tactical Humanitarian Operations Response (THOR) vehicle which is equipped with private 5G Ultra Wideband (UWB), mobile edge compute, and multiple backhaul options;
  • Satellite Picocell on Trailer (SPOT) which supports up to 400 users with satellite backhaul and WiFi access;
  • Off-Grid, Cross-Communications Network (OXEN) trailer that offers 5G UWB, 4G LTE, satellite backhaul, and solar or generator power capabilities;
  • Tactical Command Center that provides multiple critical communications options in a large secured workspace for 25 First Responders.

These assets, along with others on display, demonstrate how satellite-enabled connectivity ensures reliable and interoperable communications during disasters, emergencies and large-scale events, providing public safety officials a firsthand view of how satellite-enabled connectivity is transforming emergency response and public safety. The demonstration coincides with heightened safety measures in New Orleans, underscoring the importance of robust, dependable communication networks.

Darren Ludington, Regional Vice President Americas at ST Engineering iDirect, emphasized the impact of the company’s contributions, “Our satellite technology is a critical enabler of Verizon’s mission to provide reliable, seamless connectivity for first responders when it matters most. Our long-standing partnership with Verizon is a testament to how innovation in satellite communications can enhance public safety preparedness on a significant scale.”

Stuart Burson, Director Verizon Satellite Solutions Group, said, “The integration of ST Engineering iDirect’s satellite solutions enables us to deliver unparalleled connectivity to first responders, ensuring they remain operational under all circumstances. Together, we are redefining what’s possible in public safety communications.”

Developed over three decades of partnership with public safety officials and agencies, Verizon Frontline has been integral to emergency preparedness. In 2024 alone, the Verizon Frontline Crisis Response Team was deployed nearly 900 times across the U.S.

For more information about ST Engineering iDirect and its collaboration with Verizon Frontline, visit https://www.vzwtechnologies.com/super-bowl-tours/2025-assets-tour

ST Engineering iDirect, a subsidiary of ST Engineering, is a global leader in satellite communications (satcom) providing technology and solutions that enable its customers to expand their business, differentiate their services and optimize their satcom networks. With over 40 years of delivering innovation focused on solving satellite’s most critical economic and technology challenges we are committed to shaping the future of how the world connects. The product portfolio, branded iDirect, represents the highest standards in performance, efficiency and reliability, making it possible for its customers to deliver the best satcom connectivity experience anywhere in the world. ST Engineering iDirect is a leader in key industries including mobility, broadcast and military/government. In 2007, iDirect Government was formed to better serve the U.S. government and defense communities. For more information visit www.idirect.net.

Logo – https://laotiantimes.com/wp-content/uploads/2025/02/st_engineering_idirect_logo__002_logo-1.jpg

Meridian Flight Systems Joins Altair Aerospace Startup Acceleration Program (ASAP)

Meridian to utilize Altair software and services to enhance development of Corra UAV and HERMES projects

TROY, Mich., Feb. 6, 2025 /PRNewswire/ — Altair (Nasdaq: ALTR), a global leader in computational intelligence, is thrilled to welcome Meridian Flight Systems to the Altair Aerospace Startup Acceleration Program (ASAP). Within ASAP, Meridian will utilize Altair’s next-generation simulation, data analytics, and high-performance computing (HPC) software and technical support to enhance the development of the Corra unmanned aerial vehicle (UAV) and its Hybrid Electric Range-Extending Microturbine Energy System (HERMES).

Altair is welcoming Meridian Flight Systems to the Altair Aerospace Startup Acceleration Program (ASAP). Within ASAP, Meridian will utilize Altair’s software and services to enhance development of Corra UAV and HERMES projects.
Altair is welcoming Meridian Flight Systems to the Altair Aerospace Startup Acceleration Program (ASAP). Within ASAP, Meridian will utilize Altair’s software and services to enhance development of Corra UAV and HERMES projects.

“Meridian marks yet another fantastic addition to ASAP. We are excited to collaborate with them to push innovation in the development of heavy-lift UAVs,” said Pietro Cervellera, senior vice president of aerospace and defense, Altair. “With our world-class software and technical support, we look forward to seeing what technologies arise from the Corra and HERMES projects.”

“Joining ASAP marks a significant advancement in our mission to develop cutting-edge UAV and hybrid power technologies,” said Saïf-Deen Akanni, chief executive officer and chief technical officer, Meridian Flight Systems. “Altair’s best-in-class software solutions and technical expertise will be instrumental in optimizing the design and performance of the Corra UAV, while accelerating the development of the Hybrid Electric Range-extending Microturbine Energy System (HERMES) towards achieving airworthiness certification and operational readiness.”

Altair’s solutions and guidance will enable Meridian to optimize design processes, perform sophisticated simulations, and expedite the Corra UAV and HERMES projects from conception to certification and deployment. The collaboration’s key aspects include:

  • Comprehensive Software Access: Meridian will utilize Altair’s advanced simulation and optimization software, encompassing aerodynamics, structural integrity, aeroelastics, and thermal systems.
  • Dedicated Technical Support: Altair will provide expert guidance to ensure effective application of its software in complex aerospace projects.
  • Collaborative Research Initiatives: Both companies will coauthor research papers and present at industry conferences, sharing insights and new data derived from the Corra UAV and HERMES projects.

Meridian will demonstrate how Altair’s simulation tools facilitate the design, performance, and certification processes for both the Corra UAV and HERMES projects. This collaboration exemplifies a shared dedication to advancing aerospace innovation through rigorous analysis, data-driven research, and the broad dissemination of knowledge.

To learn more about ASAP, visit https://altair.com/aerospace-startup-acceleration-program. To learn more about Meridian, visit https://www.meridianflight.com/.

About Altair
Altair is a global leader in computational intelligence that provides software and cloud solutions in simulation, high-performance computing (HPC), data analytics, and AI. Altair enables organizations across all industries to compete more effectively and drive smarter decisions in an increasingly connected world – all while creating a greener, more sustainable future. To learn more, please visit www.altair.com.

Media contacts

Altair Corporate                                               

Altair Investor Relations

Bridget Hagan                                                   

Stephen Palmtag

+1.216.769.2658                                             

+1.669.328.9111

corp-newsroom@altair.com                     

ir@altair.com

Altair Europe/The Middle East/Africa     

Altair Asia-Pacific

Louise Wilce                                                       

Man Wang

+44 (0)7392 437 635

86-21-5016635,,825

emea-newsroom@altair.com                   

apac-newsroom@altair.com

 

 

Henlius and Dr. Reddy’s Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

SHANGHAI, Feb. 6, 2025 /PRNewswire/ — Shanghai Henlius Biotech, Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of Dr. Reddy’s Laboratories Ltd., (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY, along with its subsidiaries hereafter referred to as “Dr. Reddy’s”) for the company’s independently developed investigational daratumumab biosimilar HLX15, a recombinant anti-CD38 fully human monoclonal antibody injection. Dr. Reddy’s will gain exclusive rights to commercialize both subcutaneous and intravenous formulation of HLX15 in a total of 43 countries and regions, comprising 42 European countries and regions and the United States (U.S.).

Under the terms of the agreement, Henlius will be responsible for development, manufacturing and commercial supply, and may receive up to a total of $131.6 million, including a $33 million upfront payment and additional milestone payments. In addition, Henlius is eligible to receive royalties on annual net sales of the product. Dr. Reddy’s is a global pharmaceutical company, operating in over 75 countries across the globe. Through a partnership with Dr. Reddy’s, Henlius aims to boost the growth and reach of its products in the European and U.S. markets, providing local patients with enhanced treatment options.

“This collaboration with Dr. Reddy’s on HLX15 is a significant step in our response to global health needs and improving access to advanced biologics,” said Dr. Jason Zhu, Executive Director and Chief Executive Officer of Henlius. “Dr. Reddy’s has a long-standing dedication to oncology, driven by the purpose that ‘Good Health Can’t Wait’, and is committed to timely access to affordable and high-quality medicines, which complement Henlius’ focus on addressing unmet medical needs in research and development. We are confident that this partnership will enhance the global market competitiveness of both organizations in oncology treatment, ultimately allowing us to reach and support more patients around the world.”

“We are pleased to join hands with Dr. Reddy’s, signifying a pivotal moment in Henlius’ journey to expand our global partner network,” said Ping Cao, Chief Business Development Officer and SVP of Henlius, “Henlius’ robust product development capabilities in biosimilars, along with its advanced manufacturing and quality systems that meet global standards, paired with Dr. Reddy’s vast experience and resources in the global commercialization of biosimilars, positions this collaboration to effectively harness the strengths of both organizations. Together, we aim to deliver more high-quality and affordable treatment options to the U.S. and European markets.”

Erez Israeli, Chief Executive Officer of Dr. Reddy’s, said: “We are pleased to collaborate with Henlius to make this daratumumab biosimilar available to patients in the U.S., and Europe. Over the years, we have created a portfolio of biosimilar products that are being marketed in several emerging markets. This latest collaboration with Henlius further progresses our regulated markets journey in biosimilars. Additionally, oncology has been a top focus therapy area for us. We look forward to leveraging our strong commercial capabilities in these markets to ensure patients receive access to best-in-class therapies and affordable treatment options.”

About HLX15

HLX15 is a fully human anti-CD38 IgG1κ monoclonal antibody independently developed by Henlius, and is a biosimilar candidate to Darzalex® & Darzalex Faspro®* which are indicated for the treatment of multiple myeloma. In accordance with the biosimilar guidelines of NMPA, EMA, and USFDA, HLX15 is being developed following the principles of stepwise development. HLX15 and reference daratumumab are considered comparable based on analytical similarity assessment and pre-clinical studies. In June 2024, the Phase 1 clinical study (NCT05679258) of HLX15 was successfully completed, meeting its primary endpoint. The findings indicate that HLX15 had similar pharmacokinetic characteristics, as well as comparable safety and immunogenicity profiles to the US-, EU-, and CN-sourced daratumumab. Comparative efficacy studies are currently underway.

*Darzalex® & Darzalex Faspro® are registered trademarks of Johnson & Johnson.

About Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com.

About Henlius

Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 6 products have been launched in China, 4 have been approved for marketing in overseas markets, and 4 marketing applications have been accepted for review in China, the U.S. and the EU, respectively. Since its inception in 2010, Henlius has built an integrated biopharmaceutical platform with core capabilities of high-efficiency and innovation embedded throughout the whole product life cycle including R&D, manufacturing and commercialization. It has established global innovation centre and Shanghai-based commercial manufacturing facilities certificated by China, the EU and U.S. GMP.

Henlius has pro-actively built a diversified and high-quality product pipeline covering over 50 molecules and has continued to explore immuno-oncology combination therapies with proprietary HANSIZHUANG (anti-PD-1 mAb) as the backbone. To date, the company’s launched products include HANLIKANG (rituximab), the first China-developed biosimilar, HANQUYOU (trastuzumab, trade name: HERCESSI™ in the U.S., Zercepac® in Europe), a China-developed mAb biosimilar approved in China, Europe and U.S., HANDAYUAN (adalimumab), HANBEITAI (bevacizumab), HANSIZHUANG (serplulimab, trade name: Hetronifly® in the EU), the world’s first anti-PD-1 mAb for the first-line treatment of SCLC, and HANNAIJIA (neratinib). What’s more, Henlius has conducted over 30 clinical studies for 16 products, expanding its presence in major markets as well as emerging markets.